0001237899-12-000056.txt : 20120521 0001237899-12-000056.hdr.sgml : 20120521 20120521153006 ACCESSION NUMBER: 0001237899-12-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120518 FILED AS OF DATE: 20120521 DATE AS OF CHANGE: 20120521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHOOTER ERIC M CENTRAL INDEX KEY: 0001225472 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12858689 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0305 4 2012-05-18 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225472 SHOOTER ERIC M 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2012-05-18 4 M 0 2000.0 18.61 A 2000.0 D Common Stock 2012-05-18 4 S 0 2000.0 124.04 D 0.0 D Common Stock 2012-05-21 4 M 0 8000.0 18.61 A 8000.0 D Common Stock 2012-05-21 4 S 0 8000.0 123.23 D 0.0 D Common Stock 2012-05-21 4 M 0 10000.0 24.41 A 10000.0 D Common Stock 2012-05-21 4 S 0 10000.0 124.07 D 0.0 D Common Stock 5000.0 I by Trust Non-Qualified Stock Option (right to buy) 18.61 2012-05-18 4 M 0 2000.0 D 2019-01-02 Common Stock 2000.0 8000.0 D Non-Qualified Stock Option (right to buy) 18.61 2012-05-21 4 M 0 8000.0 D 2019-01-02 Common Stock 8000.0 0.0 D Non-Qualified Stock Option (right to buy) 24.41 2012-05-21 4 M 0 10000.0 D 2020-01-04 Common Stock 10000.0 5000.0 D Represents volume-weighted average price of sales of 2,000 shares of Company stock on May 18, 2012 at prices ranging from $124.05 to $124.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 18, 2012 at each separate price. Represents volume-weighted average price of sales of 8,000 shares of Company stock on May 21, 2012 at prices ranging from $123.00 to $123.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2012 at each separate price. Represents volume-weighted average price of sales of 10,000 shares of Company stock on May 21, 2012 at prices ranging from $124.00 to $124.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2012 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Eric M. Shooter 2012-05-21